We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MBX market cap is 680.38M. The company's latest EPS is USD -0.9744 and P/E is -20.81.
| Quarter End | Sep 2024 | |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 0 | |
| Operating Income | -19.61M | |
| Net Income | -18.14M |
| Year End 31 December 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 |
| Operating Income | -25.16M | -35.31M |
| Net Income | -26.14M | -32.56M |
| Quarter End | Sep 2024 | |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 282.4M | |
| Total Liabilities | 11.03M | |
| Total Equity | 271.37M |
| Year End 31 December 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 45.1M | 84.18M |
| Total Liabilities | 3.82M | 4.29M |
| Total Equity | -42.61M | -72.47M |
| Market Cap | 680.38M |
| Price to Earnings Ratio | -20.81 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 22.2 |
| Price to Book Ratio | 8.48 |
| Dividend Yield | - |
| Shares Outstanding | 33.42M |
| Average Volume (1 week) | 320.63k |
| Average Volume (1 Month) | 197.59k |
| 52 Week Change | -11.48% |
| 52 Week High | 26.19 |
| 52 Week Low | 15.31 |
| Spread (Intraday) | 14.22 (63.2%) |
| Company Name | MBX Biosciences Inc |
| Address |
the corporation trust company wilmington, delaware 19801 |
| Website | https://www.mbxbio.com. |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
